Literature DB >> 1373560

Successful treatment of methimazole-induced agranulocytosis by granulocyte colony-stimulating factor.

K Yokoyama, T Sato, S Nakajima, M Chino, S Komatsumoto, M Nara, S Okamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1373560     DOI： 10.1002/ajh.2830400120

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Erysipelas in neutropenia of unknown origin, successfully treated with r-metHuG-CSF (filgrastim)

Authors:  M Müller-Lühr; N Breyer; A Martin; H Haacke
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

Review 2.  Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.

Authors:  W N Patton; S B Duffull
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

3.  Risks of rhG-CSF treatment in drug-induced agranulocytosis.

Authors:  H Demuynck; P Zachée; G E Verhoef; M Schetz; G Van den Berghe; P Lauwers; M A Boogaerts
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

4.  Agranulocytosis induced by antithyroid therapy: effects of treatment with granulocyte colony stimulating factor.

Authors:  D Adorf; K H Grajer; W Kaboth; C Nerl
Journal:  Clin Investig       Date:  1994-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.